I am interested in comparing samples of type A to samples of type B. There are several RNA-seq datasets in GEO that have either type A or type B, but not both. Is it possible to take samples from two different datasets and compare them? I am guessing most of the observed differences will be between the two labs and not between the two conditions. Is that a reasonable concern? Is there a proper way to deal with that?
Unconfigured Ad
Collapse
X
-
I'd be very hesitant to do such a comparison due to the uncontrolled batch effect. I suppose you could try to estimate what sort of batch effect exists by looking at the effect between only the B or A samples, but I'm not sure how well that would work in practice.
-
-
Since with sequencing, there is much more confidence in the observations, which have a built in noise check during the mapping, and it is necessary to account for the overall differences in reads anyway comparing samples from different labs should be straight forward, unlike micro arrays, where batch effects were known to dominate in some cases requiring a high number of technical replicates.
After taking overall read depth into account, you would have to look for subtle effects like bias in GC annealing temperatures or PCR duplicates. Verifying the results in the lab may be difficult though, as with any meta-analysis.
Comment
-
-
There are still batch effects in RNAseq, though they're certainly less of an issue than in the microarray days. I happen to be looking at all of the publicly available mouse hippocampus RNAseq datasets at the moment and decided to create a little heatmap of the variance stabilised data, which you can find below. The datasets are color coded the same on the rows and columns to make life easier (there are 160 samples in the heatmap, so the labels are illegible). While there are obvious experimental differences in some of these datasets, there's still a lab batch-effect. Having said that, if you're interested in different organs or something like that then the difference due to that will be vastly greater than the batch-effect, so rskr's advise should hold-up quite well.
BTW, some of the red-colored samples are technical replicates that I never bothered merging, which is why they cluster the way they do.
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 12:17 PM
|
0 responses
13 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 12:17 PM
|
||
|
Started by SEQadmin2, 07-23-2026, 11:41 AM
|
0 responses
12 views
0 reactions
|
Last Post
by SEQadmin2
07-23-2026, 11:41 AM
|
||
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
23 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|
||
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
37 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
Comment